see
editori
commentari
mcelhaney
mcneil
page
background
data
rel
contribut
influenza
viru
respiratori
pathogen
respiratori
infect
communitydwel
older
adult
year
need
method
prospect
observ
cohort
studi
perform
netherland
winter
nasopharyng
oropharyng
swab
collect
influenzalik
ill
ili
episod
control
virus
bacteria
identifi
multiplex
ligationdepend
probe
amplif
assay
convent
bacteri
cultur
result
ili
incid
consecut
season
influenza
viru
caus
ili
episod
potenti
pathogen
detect
ili
event
influenza
viru
coronavirus
rhinovirus
human
metapneumoviru
respiratori
syncyti
viru
parainfluenza
virus
haemophilu
influenza
common
influenza
vaccin
reduc
influenza
viru
infect
confid
interv
ci
ci
ili
patient
howev
ili
incid
similar
vaccin
nonvaccin
particip
respect
p
conclus
influenza
viru
frequent
pathogen
older
adult
ili
vaccin
reduc
number
influenza
viru
infect
overal
number
ili
episod
pathogen
fill
gap
suggest
exist
pool
individu
high
suscept
respiratori
infect
clinic
trial
registr
influenza
viru
caus
season
epidem
result
million
sever
case
death
global
year
elderli
person
individu
certain
medic
condit
children
age
year
highest
risk
complic
vaccin
import
tool
prevent
infect
reduc
morbid
mortal
netherland
individu
age
year
offer
annual
influenza
vaccin
howev
public
accept
vaccin
moder
vaccin
effect
vari
per
season
depend
age
health
recipi
antigen
match
vaccin
strain
circul
strain
furthermor
scientif
debat
methodolog
determin
discuss
reach
media
influenc
gener
opinion
influenza
vaccin
benefit
moreov
public
flu
caus
influenza
viru
influenzalik
ill
ili
caus
respiratori
pathogen
influenza
vaccin
protect
consequ
influenza
vaccin
perceiv
ineffect
vaccin
uptak
reduc
counter
trend
data
rel
contribut
influenza
viru
respiratori
infect
ili
older
communitydwel
adult
lack
need
group
underrepres
dutch
primari
care
sentinel
surveil
system
definit
absent
dutch
sentinel
nurs
home
surveil
network
also
case
mani
studi
worldwid
aim
prospect
observ
studi
determin
rel
contribut
influenza
viru
respiratori
pathogen
ili
older
adult
age
year
consecut
season
netherland
addit
influenza
estim
season
upon
ili
determin
presenc
potenti
pathogen
pharynx
particip
within
hour
symptom
onset
control
analyz
sampl
individu
taken
recoveri
week
subset
asymptomat
control
potenti
pathogen
prospect
observ
studi
conduct
consecut
influenza
season
decemb
april
octob
may
netherland
adult
age
year
recruit
gener
practition
civil
registri
second
season
particip
reinvit
addit
particip
recruit
civil
registri
also
start
earlier
use
monitor
period
dutch
sentinel
surveil
system
exclus
criteria
studi
influenza
vaccin
statu
record
particip
part
studi
entir
durat
season
contact
end
season
verifi
particip
written
inform
consent
obtain
particip
trialrel
activ
conduct
accord
good
clinic
practic
includ
provis
declar
helsinki
studi
approv
acknowledg
ethic
committe
metc
noord
holland
http
wwwtrialregisternl
particip
instruct
ili
symptom
accord
dutch
pel
criteria
defin
fever
least
symptom
headach
myalgia
sore
throat
cough
rhiniti
chest
pain
report
ili
soon
possibl
onset
research
nurs
perform
home
visit
within
hour
fever
onset
acut
phase
nasopharyng
oropharyng
swab
obtain
addit
inform
demograph
comorbid
record
second
visit
recoveri
phase
perform
week
week
later
sampl
collect
new
ili
episod
report
particip
visit
second
season
control
group
asymptomat
particip
equal
distribut
differ
age
group
season
sampl
question
nasopharyng
oropharyng
sampl
obtain
steril
swab
flock
nylon
tip
store
separ
ml
modifi
liquid
ami
transport
medium
eswab
copan
brescia
itali
sampl
transport
room
temperatur
laboratori
process
store
within
hour
sampl
dna
rna
isol
swab
easymag
isol
elut
buffer
netherland
five
microlit
use
detect
panel
respiratori
virus
bacteria
realtim
polymeras
chain
reaction
pcr
base
multiplex
ligationdepend
probe
amplif
mlpa
assay
respifind
smart
kit
pathofind
netherland
analys
perform
roch
lightcycl
mlpa
analysi
perform
swab
separ
particip
exclud
analysi
consid
miss
either
swab
data
swab
miss
mlpa
data
analysi
particip
consid
posit
target
least
swab
particip
posit
influenza
virusposit
sampl
subtyp
realtim
reversetranscript
pcr
use
roch
lightcycl
system
slightli
modifi
protocol
describ
previous
convent
cultur
oropharyng
swab
perform
streptococcu
pneumonia
haemophilu
influenza
accord
standard
procedur
discrimin
h
influenza
haemophilu
haemolyticu
perform
matrixassist
laser
desorptionionizationtim
flight
malditof
particip
without
avail
oropharyng
swab
exclud
analysi
design
miss
analysi
contribut
influenza
viru
sampl
size
ili
case
estim
requir
base
expect
ili
incid
dropout
rate
cohort
size
particip
calcul
base
result
first
season
particip
includ
second
season
pearson
test
independ
sampl
test
mean
appli
analyz
particip
characterist
spss
window
softwar
p
valu
consid
signific
incid
differ
virus
bacteria
calcul
percentag
swab
posit
potenti
pathogen
number
ili
event
season
attack
rate
calcul
percentag
detect
pathogen
per
number
monitor
particip
vaccin
effect
determin
testneg
design
analysi
ili
posit
particip
influenzaact
period
analysi
restrict
period
influenza
viru
circul
netherland
particular
season
defin
nation
influenza
surveil
weekli
report
particip
day
date
vaccin
date
home
visit
exclud
analysi
uncertain
whether
vaccin
alreadi
effect
period
second
third
ili
period
includ
analysi
earlier
ili
period
influenza
viru
neg
ili
particip
influenza
viru
posit
consid
case
influenza
neg
control
calcul
odd
ratio
confid
interv
ci
calcul
per
influenza
viru
subtyp
lineag
follow
factor
regard
potenti
confound
period
season
earli
late
season
sex
smoke
comorbid
age
natur
smooth
spline
degre
freedom
associ
potenti
confound
influenza
viru
posit
subtyp
analyz
univari
logist
regress
variabl
p
consid
multivari
analysi
variabl
chang
least
includ
final
multivari
logist
regress
model
influenza
subtyp
backward
select
analys
perform
sa
version
softwar
sensit
analys
perform
analys
control
group
supplementari
materi
prospect
studi
observ
ili
incid
consecut
season
respect
figur
tabl
averag
age
vaccin
individu
significantli
higher
unvaccin
individu
respect
vs
year
vs
year
tabl
asymptomat
control
second
season
older
often
vaccin
compar
overal
cohort
figur
tabl
furthermor
particip
report
comorbid
vaccin
significantli
often
particip
report
comorbid
tabl
signific
differ
found
individu
without
ili
respect
sex
age
chronic
ill
tabl
importantli
differ
found
incid
ili
episod
vaccin
unvaccin
particip
tabl
acut
ili
sampl
season
least
potenti
pathogen
could
identifi
mlpa
bacteri
cultur
sampl
acut
phase
potenti
pathogen
detect
specif
combin
virus
andor
bacteria
observ
data
shown
recoveri
sampl
week
acut
ili
potenti
pathogen
detect
case
respect
asymptomat
control
sampl
similar
potenti
pathogen
observ
recoveri
sampl
figur
influenza
viru
detect
acut
ili
sampl
predominantli
subtyp
figur
supplementari
tabl
influenza
viru
detect
correspond
recoveri
sampl
season
suggest
influenza
viru
actual
caus
ili
influenza
viru
detect
acut
ili
sampl
circul
subtyp
detect
byamagata
lineag
bvictoria
lineag
addit
influenza
viru
detect
low
level
recoveri
sampl
sampl
asymptomat
control
respect
investig
virus
bacteria
detect
ili
episod
ili
sampl
potenti
pathogen
influenza
viru
detect
figur
supplementari
tabl
coronavirus
common
human
subtyp
human
metapneumoviru
hmpv
rhinovirus
respiratori
syncyti
viru
rsv
parainfluenza
virus
detect
ili
sampl
least
season
hmpv
rhinoviru
vari
season
virus
detect
low
level
recoveri
control
sampl
rare
viru
observ
ili
event
recoveri
sampl
except
rhinovirus
detect
frequent
visit
test
detect
rhinoviru
gener
exclud
differ
serotyp
attack
rate
influenza
viru
significantli
higher
second
season
compar
first
season
p
tabl
interestingli
increas
attack
rate
could
attribut
signific
increas
attack
rate
bvictorialik
subtyp
byamagatalik
subtyp
p
p
p
respect
wherea
attack
rate
subtyp
significantli
differ
season
virus
observ
signific
increas
attack
rate
second
season
rhinoviru
p
parainfluenza
virus
p
wherea
hmpv
attack
rate
significantli
lower
second
season
p
virus
similar
attack
rate
season
bacteri
speci
detect
convent
cultur
signific
number
acut
ili
case
h
influenza
frequent
sole
pathogen
presenc
bacteria
h
haemolyticu
pneumonia
low
haemophilu
influenza
also
detect
frequent
recoveri
control
sampl
evalu
whether
influenza
vaccin
reduc
overal
influenza
viru
infect
incid
whether
influenc
incid
ili
although
influenza
viru
lost
followup
ili
report
per
protocol
ili
report
subject
could
multipl
ili
episod
per
season
ili
visit
consid
window
sampl
taken
hour
start
fever
recoveri
visit
window
week
ili
onset
subject
consid
lost
followup
respond
end
studi
mail
ili
visit
baselin
visit
perform
subject
could
ili
event
subject
consid
lost
followup
respond
end
studi
mail
ili
visit
b
infect
incid
significantli
lower
influenza
vaccin
unvaccin
individu
tabl
incid
ili
case
reduc
vaccin
tabl
among
particip
ili
observ
high
ci
moder
ci
influenza
viru
influenzaact
period
tabl
furthermor
predomin
influenza
viru
subtyp
ci
influenza
viru
type
ci
addit
sensit
analys
multipl
ili
household
ili
presenc
absenc
viru
infect
affect
conclus
supplementari
tabl
studi
cohort
communitydwel
older
adult
netherland
show
influenza
viru
present
ili
case
consecut
season
influenza
vaccin
significantli
reduc
laboratoryconfirm
influenza
viru
infect
acut
ili
case
potenti
pathogen
influenza
viru
detect
addit
pathogen
often
present
ili
recoveri
asymptomat
elderli
person
ili
case
potenti
pathogen
detect
incid
ili
case
expect
decreas
reduct
influenza
viruscaus
ili
vaccin
howev
effect
observ
instead
incid
c
individu
asymptomat
subset
select
evenli
distribut
differ
age
group
therefor
overal
vaccin
level
higher
asymptomat
subset
compar
ili
nonili
group
ili
remain
vaccin
nonvaccin
individu
influenza
vaccin
offer
individu
year
older
netherland
older
adult
increas
risk
morbid
mortal
influenza
viru
infect
due
age
immun
system
agerel
chronic
ill
howev
polici
base
studi
mostli
perform
elderli
person
nurs
home
substanti
older
frail
compar
communitydwel
elderli
individu
studi
communitydwel
older
adult
scarc
restrict
number
pathogen
analyz
surveil
studi
fill
gap
knowledg
recruit
particip
gener
practition
civil
registri
result
particip
live
commun
line
riskbas
vaccin
strategi
western
world
older
particip
particip
chronic
condit
like
vaccin
age
distribut
cohort
similar
observ
year
gener
dutch
popul
oldest
age
group
year
underrepres
tabl
elderli
person
often
less
like
particip
studi
healthi
user
effect
frailti
select
bia
wellknown
issu
observ
influenza
vaccin
studi
frail
elderli
person
difficult
reach
found
influenza
viru
involv
ili
case
season
studi
addit
coronavirus
rhinovirus
hmpv
rsv
parainfluenza
virus
h
influenza
frequent
observ
sole
detect
pathogen
acut
ili
case
wherea
low
absent
recoveri
sampl
howev
rhinovirus
bacterium
h
influenza
also
commonli
detect
asymptomat
control
rhinovirus
may
differ
subtyp
type
virus
virus
often
detect
individu
without
clinic
manifest
found
sole
agent
context
diseas
commonli
consid
caus
diseas
bacteria
less
clear
commonli
carri
asymptomat
person
may
expand
respiratori
viral
infect
new
acquisit
haemophilu
influenza
may
induc
enhanc
inflammatori
state
presenc
pathogen
shown
children
may
lead
ili
howev
ili
case
found
h
influenza
find
second
pathogen
could
also
explain
ili
symptom
influenza
viru
incid
cohort
broadli
match
incid
report
dutch
sentinel
surveil
system
report
high
ili
incid
mortal
season
underlin
potenti
differ
gener
healthi
communitydwel
elderli
person
gener
frail
institution
elderli
person
may
overlap
age
also
show
data
acquir
one
group
necessarili
appli
includ
exposur
suscept
infect
well
influenza
show
incid
influenza
viru
infect
reduc
individu
receiv
influenza
vaccin
laboratoryconfirm
influenza
viru
infect
high
moder
season
ci
data
wide
probabl
due
rel
small
sampl
size
common
problem
similar
studi
estim
notori
variabl
studi
data
studi
line
report
van
der
hoek
et
al
strike
find
studi
similar
incid
ili
case
observ
vaccin
nonvaccin
individu
may
explain
assum
pool
peopl
exist
highli
suscept
respiratori
infect
reduct
vaccin
number
case
caus
influenza
viru
infect
offset
rise
number
case
caus
infect
pathogen
cowl
et
al
describ
similar
increas
risk
noninfluenza
respiratori
viru
infect
influenzavaccin
children
howev
attribut
effect
specif
pathogen
influenza
viru
may
take
prefer
virus
prevent
fill
nich
possibl
induc
prolong
antivir
state
describ
virus
vaccin
reduc
influenza
viru
infect
pathogen
fill
gap
need
confirm
studi
whether
influenza
viru
vaccin
effect
total
number
ili
case
would
import
consequ
decis
implement
vaccin
communitydwel
older
adult
look
overal
diseas
burden
costeffect
howev
limit
studi
directli
monitor
durat
sever
diseas
ili
case
differ
diseas
hospit
regist
postili
questionnair
signific
event
report
detail
data
sever
durat
symptom
would
allow
assess
rel
risk
pose
differ
pathogen
take
account
influenza
viru
unlik
potenti
pathogen
vari
pathogen
season
combin
medic
inform
may
possibl
assembl
profil
individu
potenti
risk
ili
wors
profil
would
great
valu
public
health
profession
limit
studi
definit
ili
use
differ
world
health
organ
european
centr
diseas
prevent
control
differ
countri
although
includ
fever
cough
studi
use
dutch
pel
criteria
includ
fever
describ
specif
ili
definit
affect
number
type
pathogen
detect
falsey
et
al
show
fever
frequent
associ
influenza
viru
infect
elderli
person
compar
respiratori
infect
cough
prerequisit
pel
criteria
particip
ili
particip
influenza
virusposit
ili
report
cough
data
shown
unlik
case
miss
due
differ
definit
summari
show
influenza
viru
caus
ili
case
communitydwel
older
adult
age
year
influenza
season
netherland
leav
remaind
caus
pathogen
also
show
influenza
vaccin
effect
reduc
incid
influenza
viru
infect
reduc
ili
incid
may
import
public
health
healthcar
consequ
data
also
help
better
detail
see
supplementari
tabl
abbrevi
ci
confid
interv
vaccin
effect
correct
possibl
confound
age
group
comorbid
sex
smoke
data
calcul
influenzaact
period
netherland
defin
netherland
institut
health
servic
research
inform
public
expect
influenza
vaccin
protect
case
ili
popularli
seen
flu
supplementari
materi
avail
journal
infecti
diseas
onlin
consist
data
provid
author
benefit
reader
post
materi
copyedit
sole
respons
author
question
comment
address
correspond
author
note
